PMDA drug package insert
フマキラースミラブ粒剤
PMDA OTC drug · フマキラー・トータルシステム（株） · package insert Apr 21, 2015
Key facts
| Brand names | フマキラースミラブ粒剤 |
|---|---|
| Companies | 製造販売元／フマキラー（株）,販売会社／フマキラー・トータルシステム（株） |
| Product type | OTC drug |
| OTC risk class | 第２類医薬品 |
| OTC dosage form | その他 |
| OTC effect category | 殺虫薬 |
| Package insert date | Apr 21, 2015 |
| PMDA document key | 670177_J0601011460 |
| PMDA company code | 670177 |
At a glance
- 1–9 Package insert revisions
- None Related PMDA documents
- None Safety communications
- No PMDA review report published
- No Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: